WebEctoPharma Ltd. Unit 2, Alpha Centre. Stirling University Innovation Park. Stirling FK9 4NF. Telephone number: 01786 440099. Fax number: 01786 440091. CLINICAL TRIAL PROTOCOL. A Multicentre Phase III trial of 1,2-octanediol at 5%(w/v) (KindaPed™) compared with malathion 0.5% (w/v) (DERBAC-M LIQUID) in the treatment of head lice. WebECTOPHARMA LTD (GB) Country: European Patent Office. Date: Priority . 2001/03/02. This web page summarizes information in PubChem about patent EP-1377162-A1. This …
ECTOPHARMA LTD innovation strategy - GoodIP
WebIn the past he was Chairman at EctoPharma Ltd. He received an undergraduate degree from the University of Oxford. Matthew James Benson is on the board of Rettie & Co. and 4 other companies. In the past he was Chairman at EctoPharma Ltd. He received an undergraduate degree from the University of Oxford. WebEctopharma, Ltd., an emerging life science company, develops green pesticides and environmentally friendly insecticides, as well as biocides for veterinary, human, and environmental conditions. It offers its products for various ectoparasite treatments. The company was formerly known as Safedip Limited. Ectopharma, Ltd. is based in … how much percent did einstein used his brain
1,2-Octanediol, a Novel Surfactant, for Treating Head Louse
WebBASF Pharma (Callanish) Ltd Sep 2011 - Nov 2015 4 years 3 months. Outer Hebrides, United Kingdom Independent Business Owner Consultancy May 2010 - Sep 2011 1 year 5 months. Chief Operating Officer & Designated Individual (DI) ... EctoPharma Ltd May 2005 - May 2009 4 years 1 month. VP and Managing Director UK: Hydrogel based Drug … WebEctoPharma Ltd Original Assignee EctoPharma Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2001-03-02 Filing date 2002-02-28 Publication date 2006-09-27 Priority claimed from GB0105229 external-priority WebIn 2000, they became the CEO of EctoPharma Ltd and held that position until 2004. In 2010, they joined Giltech Ltd as their Commercial Director and then moved to Angel Biotechnology in 2012 as their Business Development Lead. In 2016, they joined 3P Biopharmaceuticals as their Head of Business Development until 2024 when they took … how much percent does amazon take